Abbonarsi

Left atrioventricular coupling index assessed using cardiac CT as a prognostic marker of cardiovascular death - 30/11/23

Doi : 10.1016/j.diii.2023.06.009 
Théo Pezel a, b, , Jean-Guillaume Dillinger a, Solenn Toupin c, Raphael Mirailles a, Damien Logeart a, Alain Cohen-Solal a, Alexandre Unger a, d, Elena Sofia Canuti a, e, Florence Beauvais a, Alexandre Lafont a, Trecy Gonçalves a, Antoine Lequipar a, Emmanuel Gall a, Alexandre Boutigny f, Tania Ah-Sing b, Lounis Hamzi b, Joao A.C. Lima g, Valérie Bousson b, Patrick Henry a
a Université Paris Cité, Department of Cardiology, Hôpital Lariboisière – APHP, Inserm UMRS 942, 75010, Paris, France 
b Université Paris Cité, Department of Radiology, Hôpital Lariboisière – APHP, 75010, Paris, France 
c Siemens Healthcare France, 93200 Saint-Denis, France 
d Department of Cardiology, Hôpital Universitaire de Bruxelles – Hôpital Erasme, 1070 Brussels, Belgium 
e Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, 00161 Rome, Italy 
f Université Paris Cité, Service des Explorations Fonctionnelles, Hôpital Lariboisière – APHP, Inserm UMRS 942, 75010, Paris, France 
g Division of Cardiology, Johns Hopkins University, Baltimore, MD 21287-0409, USA 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Highlights

The concept of left atrioventricular (AV) coupling is supported by a left AV coupling index, which has a better prognostic value than individual left atrium or left ventricle parameters measured separately.
The left AV coupling index assessed using cardiac CT demonstrates excellent intra- and inter-reader reproducibilities allowing even easier distribution.
The simple method to measure the new left AV coupling index allows rapid and immediate routine use as a cardiovascular risk stratification tool.
The left AV coupling index is independently associated with cardiovascular death in patients after adjustment for traditional risk factors and cardiac CT findings.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Purpose

The purpose of this study was to investigate the prognostic value of left atrioventricular coupling index (LACI) assessed by cardiac computed tomography (CT), to predict cardiovascular death in consecutive patients referred for cardiac CT with coronary analysis.

Materials and methods

Between 2010 and 2020, we conducted a single-centre study with all consecutive patients without known cardiovascular disease referred for cardiac CT. LACI was defined as the ratio of left atrial to left ventricle end-diastolic volumes. The primary outcome was cardiovascular death. Cox regressions were used to evaluate the association between LACI and primary outcome after adjustment for traditional risk factors and cardiac CT angiography findings.

Results

In 1,444 patients (mean age, 70 ± 12 [standard deviation] years; 43% men), 67 (4.3%) patients experienced cardiovascular death after a median follow-up of 6.8 (Q1, Q3: 5.9, 9.1) years. After adjustment, LACI was positively associated with the occurrence of cardiovascular death (adjusted hazard ratio [HR], 1.07 [95% CI: 1.05–1.09] per 1% increment; P < 0.001), and all-cause death (adjusted HR, 1.05 [95% CI: 1.03–1.07] per 1% increment; P <0.001). After adjustment, a LACI ≥ 25% showed the best improvement in model discrimination and reclassification for predicting cardiovascular death above traditional risk factors and cardiac CT findings (C-statistic improvement: 0.27; Nnet reclassification improvement = 0.826; Integrative discrimination index =0.209, all P < 0.001; likelihood-ratio-test, P < 0.001).

Conclusion

LACI measured by cardiac CT is independently associated with cardiovascular death and all-cause death in patients without known cardiovascular disease referred for cardiac CT, with an incremental prognostic value over traditional risk factors and cardiac CT findings.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : All-cause death, Cardiac computed tomography angiography, Cardiovascular death, Left atrioventricular coupling index

Abbreviations : CI, CMR, CCTA, CT, CV, CVD, HR, IDI, LACI, LR, LV, LVEF, MESA, NRI, SD


Mappa


© 2023  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 104 - N° 12

P. 594-604 - dicembre 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • What is the benefit of gadolinium-chelate injection for the diagnosis of local recurrence of clear cell renal cell carcinoma after percutaneous thermal ablation with MRI?
  • Julien Gay Depassier, Amandine Crombé, Eva Jambon, Jean-Christophe Bernhard, Yann Le Bras, Nicolas Grenier, Clément Marcelin
| Articolo seguente Articolo seguente
  • Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI
  • Ying Cao, Xiaoxia Wang, Lan Li, Jinfang Shi, Xiangfei Zeng, Yao Huang, Huifang Chen, Fujie Jiang, Ting Yin, Dominik Nickel, Jiuquan Zhang

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.